Many people notice shifts in food noise and energy before seeing changes on the scale
We monitor your progress closely to ensure your weight loss velocity remains within a safe, sustainable range
Retatrutide holds no MHRA or EMA marketing authorisation and is not available through legitimate UK pharmacies
Safety Comparison Table# Research Evidence Comparison# Amycretin Research# Amycretin has early but impressive data: Phase 1 (SC): Published in The Lancet (2025)
Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: sex differences and age-dependent changes

CONNECT WITH TARA TikTok and Instagram: @tacklingtara Links and resources: SPONSOR Tyde Wellness GLP-1 programs with licensed providers, real dosing adjustments, and long-term support code GLP1Hub50 for $50 off your first month CHAPTERS 00:00 From clinical trial to a 222-pound weight loss 01:11 Meet Tara Rothenhoefer 03:16 A lifelong battle with obesity and dieting 04:48 Finding the tirzepatide clinical trial 08:15 Taking a chance on an unknown medication 10:58 What the trial support looked like 13:56 Movement, nutrition support, and early results 16:54 Losing 132 pounds in 18 months 20:00 When the trial ended and medication access disappeared 29:00 Shortages, stigma, and public attention 35:11 When weight loss went too far 40:24 Long-term maintenance and listening to her body 43:03 Connecting with Tara MORE FROM GLP-1 HUB Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show
